Inovio Pharmaceuticals Stock Investor Sentiment
| INO Stock | USD 10.20 0.87 7.86% |
About 54% of Inovio Pharmaceuticals' investor base is interested to short. The analysis of the overall investor sentiment regarding Inovio Pharmaceuticals suggests that many traders are impartial. Inovio Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Inovio Pharmaceuticals. The current market sentiment, together with Inovio Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Inovio Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Inovio Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Inovio daily returns and investor perception about the current price of Inovio Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Inovio |
Inovio Pharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Inovio Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Inovio Pharmaceuticals that are available to investors today. That information is available publicly through Inovio media outlets and privately through word of mouth or via Inovio internal channels. However, regardless of the origin, that massive amount of Inovio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inovio Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inovio Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inovio Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inovio Pharmaceuticals alpha.
Inovio Pharmaceuticals Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Inovio Pharmaceuticals Announces 1-for-12 Reverse Stock Split - TipRanks.com - TipRanks | 01/26/2024 |
2 | Disposition of 1878 shares by Laurent Humeau of Inovio Pharmaceuticals subject to Rule 16b-3 | 02/26/2024 |
3 | IPX Unveiled Its First PFP Project, WADESIDE, Elevating the Dynamics Between Authentic IP Activities and NFT Value Growth | 02/27/2024 |
4 | CymaBay Therapeutics Inc. Reports Q4 Loss, Misses Revenue Estimates | 02/28/2024 |
5 | INO Stock Earnings Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023 | 03/07/2024 |
6 | Inovio Pharmaceuticals Full Year 2023 Earnings Misses Expectations | 03/08/2024 |
7 | Inovio Pharmaceuticals Inc Stock Is Higher By 12.97 percent This Week Buy, Hold, or Sell - InvestorsObserver | 03/13/2024 |
8 | Inovio Pharmaceuticals, Inc. Revenue Breakdown NASDAQINO TradingView - TradingView | 03/28/2024 |
9 | INOVIO Announces Pricing of Approximately 36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | 04/15/2024 |
10 | Inovio stock falls after pricing stock offering | 04/16/2024 |
Check out Inovio Pharmaceuticals Hype Analysis, Inovio Pharmaceuticals Correlation and Inovio Pharmaceuticals Performance. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Inovio Stock analysis
When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.09) | Revenue Per Share 0.038 | Quarterly Revenue Growth (0.18) | Return On Assets (0.32) | Return On Equity (0.80) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.